Shanghai Henlius Biotech Inc
HKEX:2696
Wall Street
Price Targets
Price Targets Summary
Shanghai Henlius Biotech Inc
According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 35.7 HKD with a low forecast of 35.35 HKD and a high forecast of 36.75 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Henlius Biotech Inc's stock price target?
Price Target
35.7
HKD
According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 35.7 HKD with a low forecast of 35.35 HKD and a high forecast of 36.75 HKD.
What is Shanghai Henlius Biotech Inc's Revenue forecast?
Projected CAGR
6%
For the last 6 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 203%. The projected CAGR for the next 3 years is 6%.
What is Shanghai Henlius Biotech Inc's Operating Income forecast?
Projected CAGR
4%
The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 4%.
What is Shanghai Henlius Biotech Inc's Net Income forecast?
Projected CAGR
5%
The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 5%.
You don't have any saved screeners yet
